APM
Avidity Partners Management Portfolio holdings
AUM
$439M
1-Year Est. Return
34.53%
1 Year Est. Return
+34.53%
AUM
$439M
AUM Growth
-$59.4M
(-12%)
Holding
68
Top Buys
| 1 | +$57.5M | |
| 2 | +$18.2M | |
| 3 | +$11.6M | |
| 4 |
Pfizer
PFE
|
+$9.34M |
| 5 |
MTSR
Metsera Inc
MTSR
|
+$7.35M |
Top Sells
| 1 | +$20.7M | |
| 2 | +$18.7M | |
| 3 | +$18.4M | |
| 4 |
HNGE
Hinge Health
HNGE
|
+$16.7M |
| 5 |
Exact Sciences
EXAS
|
+$15.4M |
Sector Composition
| 1 | Healthcare | 99.02% |
| 2 | Consumer Staples | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Humana
HUM
$29.1B
| – | – |
-27,600
|
|
||
52
Intuitive Surgical
ISRG
$201B
| – | – |
-27,100
|
|
||
53
Kezar Life Sciences
KZR
$45.6M
| – | – |
-502,600
|
|
||
54
Madrigal Pharmaceuticals
MDGL
$13.2B
| – | – |
-19,000
|
|
||
55
MoonLake Immunotherapeutics
MLTX
$939M
| – | – |
-39,000
|
|
||
56
Intellia Therapeutics
NTLA
$975M
| – | – |
-232,000
|
|
||
57
Organon & Co
OGN
$1.98B
| – | – |
-640,000
|
|
||
58
uniQure
QURE
$1.66B
| – | – |
-207,000
|
|
||
59
Ultragenyx Pharmaceutical
RARE
$3.22B
| – | – |
-154,000
|
|
||
60
Revolution Medicines
RVMD
$14.7B
| – | – |
-228,600
|
|
||
61
Reviva Pharmaceuticals
RVPH
$71M
| – | – |
-138,000
|
|
||
62
Soleno Therapeutics
SLNO
$2.63B
| – | – |
-32,000
|
|
||
63
Syndax Pharmaceuticals
SNDX
$1.66B
| – | – |
-150,000
|
|
||
64
ARS Pharmaceuticals
SPRY
$929M
| – | – |
-140,000
|
|
||
65
Tenet Healthcare
THC
$18.9B
| – | – |
-106,000
|
|
||
|
VRNA
66
DELISTED
Verona Pharma
VRNA
| – | – |
-33,800
|
|
||
|
HNGE
67
Hinge Health
HNGE
$3.78B
| – | – |
-322,344
|
|
||
|
OMDA
68
Omada Health Inc
OMDA
$1.08B
| – | – |
-390,600
|
|